Neurogene Inc. (NGNE) Insider Ownership

Historic Ownership Trends

According to recent filings covering the 90 days ending December 12, 2025, the three most significant insider holders at Neurogene are TenPercentOwner Biocapital Gp, Llc Samsara (1.72Mn shares), Chief Executive Officer Rachel Mcminn (1.27Mn shares), Chief Scientific Officer Stuart Cobb (20.79K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Bros. Advisors Lp Baker 69,511 10 Oct, 2023
Jonathan G Drachman President And CEO 29,671 26 Aug, 2021
Biocapital Gp, Llc Samsara 1,717,127 27 Nov, 2024
Carl Walkey Senior Vice President 16,906 17 Jun, 2021
Rachel Mcminn Chief Executive Officer 1,274,259 28 Mar, 2025
Christine Mikail Cvijic President And Cfo 92,643 28 Mar, 2025
Priti Patel 466 04 Apr, 2023
Sean Michael Smith Interim CFO And Prin Acct Off 270 14 Aug, 2023
Robert Ho Chief Financial Officer 269 18 Mar, 2021
Stuart Cobb Chief Scientific Officer 20,794 15 May, 2025
Julie Jordan Chief Medical Officer 8,400 28 Mar, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
14 May, 2025 Stuart Cobb Common Stock D 6,797 $15.15 20,794 D S
26 Mar, 2025 Christine Mikail Cvijic Common Stock A 20,300 $0.00 92,643 D A
26 Mar, 2025 Julie Jordan Common Stock A 8,400 $0.00 8,400 D A
26 Mar, 2025 Rachel Mcminn - - 1,274,259 D
26 Mar, 2025 Rachel Mcminn Common Stock A 23,900 $0.00 1,274,259 D A
26 Mar, 2025 Stuart Cobb Common Stock A 7,200 $0.00 27,591 D A
13 Mar, 2025 Christine Mikail Cvijic Common Stock D 4,501 $16.94 72,343 D S
13 Mar, 2025 Christine Mikail Cvijic - - 72,343 D
26 Nov, 2024 Biocapital Gp, Llc Samsara - - 1,689,105 I
26 Nov, 2024 Biocapital Gp, Llc Samsara Common Stock A 20,748 $24.91 1,689,105 I P
26 Nov, 2024 Biocapital Gp, Llc Samsara Common Stock A 10,803 $26.01 1,699,908 I P
26 Nov, 2024 Biocapital Gp, Llc Samsara - - 1,699,908 I
26 Nov, 2024 Biocapital Gp, Llc Samsara Common Stock A 15,219 $26.73 1,715,127 I P
26 Nov, 2024 Biocapital Gp, Llc Samsara - - 1,715,127 I
26 Nov, 2024 Biocapital Gp, Llc Samsara Common Stock A 2,000 $27.50 1,717,127 I P
26 Nov, 2024 Biocapital Gp, Llc Samsara - - 1,717,127 I
22 Nov, 2024 Christine Mikail Cvijic Common Stock A 24,000 $20.48 76,844 D P
22 Nov, 2024 Rachel Mcminn Common Stock A 47,500 $20.40 1,297,859 D P
13 Mar, 2024 Stuart Cobb Common Stock A 20,391 $0.00 20,391 D A
13 Mar, 2024 Stuart Cobb - - 20,391 D